At Work: Physician-Scientist Ping Chi
Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.
Friday, November 2, 2012
Alexander Rudensky Appointed Immunology Program Chair
Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.
Wednesday, September 26, 2012
Tunneling Nanotubes Connect Cancer Cells
Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
Wednesday, September 19, 2012